← Back to Search

Peanuts for Cardiometabolic Health

N/A

Waitlist Available

Research Sponsored by Loma Linda University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

adults between the ages of 18-70 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12 weeks

Awards & highlights

Study Summary

This trial will study the effects of eating peanuts on immunity and cardiometabolic health.

Who is the study for?

Adults aged 18-70 without a peanut allergy, bad dentures, or high current nut consumption can join. Those on immune supplements, recent antibiotics or corticoids, certain other meds, or vaccinated within the last 6 months are excluded.Check my eligibility

What is being tested?

The study is testing if eating peanuts improves immune function and benefits heart health markers. Participants will consume peanuts to see changes in their immunity and cardiometabolic risk factors.See study design

What are the potential side effects?

Since this trial involves peanut intake, potential side effects may include digestive discomfort for some individuals not used to consuming them regularly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in Hemoglobin A1c

Changes in Lymphocyte activity

Changes in body weight

+7 more

Secondary outcome measures

changes in upper respiratory infection questionnaire score

Trial Design

2Treatment groups

Active Control

Group I: Peanut groupActive Control1 Intervention

Participants will be consuming 2 ounces of peanuts /peanut butter everyday for 12 weeks

Group II: control groupActive Control1 Intervention

Participants will continue with habitual diet and abstain from eating peanuts

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor

306 Previous Clinical Trials

260,893 Total Patients Enrolled

California Walnut CommissionOTHER

23 Previous Clinical Trials

36,572 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this clinical trial?

"To qualify for enrollment, participants must demonstrate an immune response and be situated between 18-70 years of age. Approximately 80 individuals will be accepted to the trial."

Answered by AI

Does the eligibility for this study extend to those aged 25 and above?

"This medical trial is accepting participants that are aged 18 or above and below 70 years old."

Answered by AI

Are there any vacant positions for participants in this clinical trial?

"Clinicaltrials.gov informs us that recruitment for this study has been completed, as it was initially posted on January 25th 2024 and last updated November 28th 2023. However, 12 other trials are presently seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

Joan Sabate,DrPH, MD 2024. "Effects of Peanuts on Immunity and Cardiometabolic Risk Factors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06159556.

All > Heart Disease